SWS Academic Research eLibraryEarth & Planetary Sciences

Scholarly record

EU LEGISLATIVE SOLUTIONS REGARDING ENVIRONMENTAL RISK OF PHARMACEUTICAL PRODUCTS

Cristina-Luiza Cristina-Luiza

First published: 2017-06-29https://doi.org/10.5593/sgem2017/54/s23.038View metrics

Abstract

Considering the fact that the production of 1 kg of output in the pharmaceutical sector has a higher environmental impact than the production of 1 kg of output in the chemical industry, this article examines the way in which the specific legislation of the EU regarding medicinal products is adapted to the legislative instruments for the assessment and control of the environmental risks posed by medicinal products for human use during their life cycle, from production and up to the end of their life cycle. The European Union is the second largest consumer of medicinal products for human use (24% of the world total), after the United States of America, while the consumption phase is considered to be the greatest factor contributing to the release of medicinal products to the environment, especially by way of excretions and the improper disposal of unused medicines through sinks and toilets. As the pollution of waters and soils with pharmaceutical residues is an emerging environmental problem, the article aims to present the legal measures taken at EU level to monitor and assess the risks posed by medicinal products for human use to the environment, including those that may affect public health.

Publication Impact Profile

PlumX
  • Captures
  • Mendeley - Readers: 2
PLUMX see details

Publication details

Title
EU LEGISLATIVE SOLUTIONS REGARDING ENVIRONMENTAL RISK OF PHARMACEUTICAL PRODUCTS
Authors
Cristina-Luiza Cristina-Luiza
Proceedings
SGEM International Multidisciplinary Scientific GeoConference EXPO Proceedings; SGEM2017 17th International Multidisciplinary Scientific GeoConference
Publisher
STEF92 Technology
Year
2017
Pages
291-298
SWS Citekey
Erimia201723291298
ISSN
1314-2704
ISBN
978-619-7408-11-9
Language
en
Publication type
Conference Paper
Keywords
EU environmental legislationsenvironmental risksmedicinal products of human usethe pharmaceutical sectorEU legal frameworks
References0
0references registered for this publication

Structured references will appear here after the reference import pass. The count is preserved now so the scholarly record is not incomplete.

View or Download full articleAccess options
Full paper accessChoose SWS login, librarian support, or instant article download.

SWS access login

Login as SWS Scientific Committee

Authors and approved SWS contributors will read and export their own linked papers after identity matching by SWS profile, email and SGEM GlobalID.

For librarian assistance: [email protected]

Purchase Instant Access

48-hour online accessComing soon
Online-only accessComing soon
Download the full article in PDF formatEUR 35
  • Article can be downloaded after successful payment.
  • Article may be used according to SWS library access terms.
  • Article cannot be redistributed.
Get full paper

Back to publication list